METHOTREXATE-INDUCED ORAL ERYTHEMA MULTIFORME
DOI:
https://doi.org/10.22159/ijap.2023.v15s2.05Keywords:
Oral erythema multiforme, Adverse drug reaction, Ulceration, Saline, Hyaluronic acidAbstract
Objective: To discuss the management of oral erythema multiforme (EM) due to methotrexate (MTX) in gestational trophoblastic tumor patients.
Methods: A 28-year-old woman was referred to the Oral Medicine Clinic with complaints of pain throughout the oral cavity accompanied by blackish encrustation on the upper and lower lip for 5 d. She previously underwent the first cycle of chemotherapy using MTX for the treatment of a gestational trophoblastic tumor. Extraoral, multiple diffuse blackish patches on the face and haemorrhagic crusts on the lips with painful erosions. Intraoral, multiple erosive and ulcerative lesions on the labial and buccal mucosa.
Results: Management involved topical 0.025% hyaluronic acid mouthwash for erosion and ulceration, compressed 0.9% NaCl for crusted lesions on the lips, and petroleum jelly for the non-crusted lesions on the lips. Complete healing of oral and lip lesions was achieved within 10 d.
Conclusion: Pharmacological management should be tailored to each patient with careful consideration of treatment risk or benefit. In our case, the use of non-steroidal anti-inflammatory topical agents was considered successful in treating oral EM.
Downloads
References
Neville BW, Damm DD, Allen CM, Chi AC. Color atlas of oral and maxillofacial diseases. Philadelpia. Elsevier; 2019.
Trayes KP, Love G, Studdiford JS. Erythema multiforme: recognition and management. Am Fam Physician. 2019;100(2):82-8. PMID 31305041.
Rajendran ABS. Shafer’s textbook of oral pathology. 6th ed. New Delhi: Elsevier India; 2009.
Joseph TI, Vargheese G, George D, Sathyan P. Drug-induced oral erythema multiforme: a rare and less recognized variant of erythema multiforme. J Oral Maxillofac Pathol. 2012;16(1):145-8. doi: 10.4103/0973-029X.92995, PMID 22434953.
Nazir A, Ali K. Drug-induced erythema multiforme-oral variant: a case report. Oral Maxillofac Surg Cases. 2022;8(1). doi: 10.1016/j.omsc.2021.100241.
Coleman JJ, Pontefract SK. Adverse drug reactions. Clin Med. 2016 Oct;16(5):481-5. doi: 10.7861/clinmedicine.16-5-481.
Kaufman G. Adverse drug reactions: classification, susceptibility and reporting. Nurs Stand. 2016;30(50):53-63. doi: 10.7748/ns.2016.e10214, PMID 27507394.
Asif SM, Shamsudeen SM, Assiri KI, Muburak Al HMA, Kaleem SM, Khan AA. Drug-induced oral erythema multiforme. Medicine. 2021;100(17):E22387. doi: 10.1097/MD.0000000000022387.
Glick M, Greenberg MS, Lockhart PB, Challacombe SJ. Burket’s oral medicine. 13th ed Philadelpia: Wiley Blackwell; 2021.
Issrani R. Etiopathogenesis of erythema multiforme–a concise review. ADOH. 2017;5(4). doi: 10.19080/ADOH.2017.05.5555669.
Aswath N, Rakshana R. Drug-induced erythema multiforme of the oral cavity. Arch Clin Cases. 2022;9(4):157-60. doi: 10.22551/2022.37.0904.10224, PMID 36628160.
Patel TK, Barvaliya MJ, Sharma D, Tripathi C. A systematic review of the drug-induced Stevens-Johnson syndrome and toxic epidermal necrolysis in Indian population. Indian J Dermatol Venereol Leprol. 2013;79(3):389-98. doi: 10.4103/0378-6323.110749, PMID 23619444.
Bedoui Y, Guillot X, Selambarom J, Guiraud P, Giry C, Jaffar Bandjee MC. Methotrexate an old drug with new tricks. Int J Mol Sci. 2019;20(20). doi: 10.3390/ijms20205023, PMID 31658782.
Asghar M, Shoaib H, Kang W, Tariq I, Chatterjee T. Methotrexate toxicity: a simple solution to a complex problem. Cureus. 2021;13(4):e14364. doi: 10.7759/cureus.14364, PMID 33972915.
Mishra K, Jandial A, Kumar A, Lad D, Prakash G, Khadwal A. Methotrexate and mucositis: a merry-go-round for oncologists. Indian J Med Paediatr Oncol. 2019;40(1):150-2. doi: 10.4103/ijmpo.ijmpo_113_18.
Wallin E, Niemann I, Faaborg L, Fokdal L, Joneborg U. Differences in administration of methotrexate and impact on outcome in low-risk gestational trophoblastic neoplasia. Cancers (Basel). 2022;14(3):1-11. doi: 10.3390/cancers14030852, PMID 35159119.
Sajith M, Pawar A, Bafna V, Bartakke S. Case report on hypersensitivity to methotrexate infusion in a pediatric acute lymphoblastic leukaemia patient. J Oncol Pharm Pract. 2020;26(2):462-4. doi: 10.1177/1078155219839219, PMID 30961436.
Cruz AC, Fidelis YP, Vieira LS, Figueiredo PT, Duarte DB. Methotrexate induced erythema multiforme: a case report of accidental overdose. Rev Bras Farm Hosp Serv Saude. 2021;12(3):642.
Dervisoglou T, Matiakis A. Oral ulceration due to methotrexate treatment: a report of 3 cases and literature review. Balkan J Dent Med. 2015;19(2):116-20. doi: 10.1515/bjdm-2015-0045.
Singh V, Singh AK. Oral mucositis. Natl J Maxillofac Surg. 2020;11(2):159-68. doi: 10.4103/njms.NJMS_10_20, PMID 33897175.
Bell A, Kasi A. Oral mucositis. Treasure Island, (FL): StatPearls Publishing; 2023. https://www.ncbi.nlm.nih.gov/ zbooks/NBK565848. [Last accessed on 06 Nov 2023].
Deeming GMJ, Collingwood J, Pemberton MN. Methotrexate and oral ulceration. Br Dent J. 2005;198(2):83-5. doi: 10.1038/sj.bdj.4811972, PMID 15702101.
Romao VC, Lima A, Bernardes M, Canhao H, Fonseca JE. Three decades of low-dose methotrexate in rheumatoid arthritis: can we predict toxicity? Immunol Res. 2014;60(2-3):289-310. doi: 10.1007/s12026-014-8564-6, PMID 25391609.
Lerch M, Mainetti C, Terziroli Beretta Piccoli B, Harr T. Current perspectives on erythema multiforme. Clin Rev Allergy Immunol. 2018;54(1):177-84. doi: 10.1007/s12016-017-8667-7, PMID 29352387.
Su JR, Haber P, Ng CS, Marquez PL, Dores GM, Perez Vilar S. Erythema multiforme, Stevens-Johnson syndrome, and toxic epidermal necrolysis reported after vaccination, 1999-2017. Vaccine. 2020;38(7):1746-52. doi: 10.1016/j.vaccine.2019.12.028, PMID 31870573.
Lee H, Ju H, Lee J, Jeon H, Kim K, Ok S. Treatment of drug-induced erythema multiforme: case report. JOMP. 2019;44(4):183-8. doi: 10.14476/jomp.2019.44.4.183.
Yang Z, Li M, Xiao L, Yi Z, Zhao M, Ma S. Hyaluronic acid versus dexamethasone for the treatment of recurrent aphthous stomatitis in children: efficacy and safety analysis. Braz J Med Biol Res. 2020;53(8):e9886. doi: 10.1590/1414-431X20209886, PMID 32609262.
Bruckmann C, Seemann R, Rappersberger K, Rausch Fan X, Haririan H, Dvorak G. Is topical application of hyaluronic acid in oral lichen planus effective? A randomized controlled crossover study. Appl Sci. 2020;10(22):1-14. doi: 10.3390/app10227988.
Al-Khateeb R, Olszewska Czyz I. Biological molecules in dental applications: hyaluronic acid as a companion biomaterial for diverse dental applications. Heliyon. 2020;6(4):e03722. doi: 10.1016/j.heliyon.2020.e03722, PMID 32280803.
Waingade M, Medikeri RS, Gaikwad S. Effectiveness of hyaluronic acid in the management of oral lichen planus: a systematic review and meta-analysis. J Dent Anesth Pain Med. 2022 Dec;22(6):405-17. doi: 10.17245/jdapm.2022.22.6.405, PMID 36601134.
Salami AA, Imosemi IO, Owoeye OO. A comparison of the effect of chlorhexidine, tap water and normal saline on healing wounds. Int J Morphol. 2006;24(4):673-6. doi: 10.4067/S0717-95022006000500025.
Junker JPE, Kamel RA, Caterson EJ, Eriksson E. Clinical impact upon wound healing and inflammation in moist, wet, and dry environments. Adv Wound Care. 2013;2(7):348-56. doi: 10.1089/wound.2012.0412, PMID 24587972.
Santos E, Queiros P, Cardoso D, Cunha M, Apostolo J. A eficacia das solucoes de limpeza para o tratamento de feridas: uma revisao sistematica. Rev Enf Ref. 2016;IV(9):133-43. doi: 10.12707/RIV16011.
Suryadi D, HE, Sunarya W, Nacl PK. 0,9% dengan kompres alkohol 70% terhadap penurunan intensitas nyeri pada pasien flebitis. J Kedokt Kesehat. 2015;2(3):245-51.
Jayakumar KL, Micheletti RG. Robert Chesebrough and the dermatologic wonder of petroleum jelly. JAMA Dermatol. 2017;153(11):1157. doi: 10.1001/jamadermatol.2017.3544, PMID 29117303.
Pinto JR, Monteiro E, Silva SA, Holsback VdSS, Leonardi GR. Skin occlusive performance: sustainable alternatives for petrolatum in skincare formulations. J Cosmet Dermatol. 2022;21(10):4775-80. doi: 10.1111/jocd.14782.
Czarnowicki T, Malajian D, Khattri S, Correa da Rosa J, Dutt R, Finney R. Petrolatum: barrier repair and antimicrobial responses underlying this ”inert” moisturizer. J Allergy Clin Immunol. 2016;137(4):1091-1102.e7. doi: 10.1016/j.jaci.2015.08.013, PMID 26431582.
Lefaan YM, Setiadhi R. Challenges in the management of oral manifestations in a patient with limited systemic sclerosis. Sci Dent J. 2021;5(3):148. doi: 10.4103/SDJ.SDJ_93_21.
Published
How to Cite
Issue
Section
Copyright (c) 2023 ASTRID WIDHOWATY SANTOSO, AMIRA SHAFURIA, TENNY SETIANI DEWI
This work is licensed under a Creative Commons Attribution 4.0 International License.
